CTI ClinTex is a blockchain-based platform that aims to revolutionize the pharmaceutical industry by providing a more efficient and cost-effective way of conducting clinical trials. The platform utilizes smart contracts to automate the process of data collection, analysis, and reporting, which reduces the time and cost of conducting clinical trials. CTI ClinTex also provides a secure and transparent platform for all stakeholders involved in the clinical trial process, including patients, doctors, researchers, and regulators. The platform's native cryptocurrency, CTi, is used to incentivize participants and facilitate transactions within the platform.

CTi is an ERC-20 token that is built on the Ethereum blockchain. The token is used to incentivize participants in the CTI ClinTex platform, including patients, doctors, researchers, and regulators. CTi is also used to facilitate transactions within the platform, such as payments for services and products. The token has a limited supply of 1 billion, with 500 million tokens available for sale during the initial coin offering (ICO). The remaining tokens will be used for platform development, marketing, and team incentives. Overall, CTi ClinTex and its native cryptocurrency, CTi, have the potential to transform the clinical trial industry by providing a more efficient, cost-effective, and secure platform for all stakeholders involved in the process.